admin
The new American Principles Project report and recent CBN coverage shine a bright light on a fast-growing industry that taxpayers are quietly underwriting. The video below lays out the numbers: billions in revenue, rising at double-digit speed, and federal programs like Medicare and Medicaid footing a large part of the bill. If you think government should pick winners and losers in healthcare, or should be funding risky, life-altering procedures without strict guardrails, then you might want to look away. For the rest of us, this is a wake-up call.
Taxpayer-Funded “Gender Mutilation” — The Numbers Don’t Lie
The APP report quoted in CBN’s piece pegs the so-called “gender mutilation” surgery market at $4.12 billion in 2022 and forecasts annual growth of about 8.4 percent through 2030. Those are not small potatoes. The group estimates a full set of procedures could cost from roughly $87,300 to $410,600 for males and $66,500 to $605,500 for females. Those price tags matter because, unlike abortion care where the Hyde Amendment puts limits on federal funding, many of these gender interventions can be reimbursed by Medicare and Medicaid. That makes every household a silent investor in a booming medical niche—whether they want to be or not.
Big Hospitals, Big Pharma, Big Profits
Let’s call this what it is: an industry. Hospital systems, pharmaceutical companies, and large providers have an incentive to expand services and pad their balance sheets. Add in well-known nonprofits and health centers that monetize the trend, and you have what the report calls a “gender industrial complex.” When government dollars flow freely, you encourage more procedures, more marketing, and more business models built around lifetime follow-up care. That creates a steady revenue stream for the providers and a steady drain on public coffers.
Common-Sense Steps Conservatives Should Push
We should be pro-patient and pro-transparency, not pro-subsidizing a medical market with weak oversight. First, Congress can close the funding loopholes that allow Medicare and Medicaid to reimburse elective, life-altering gender interventions without strict standards. Second, states and federal regulators should demand clear outcome reporting, age-appropriate protections, and true informed consent. Third, we need fiscal audits to track how much taxpayer money goes to these procedures and who benefits. This isn’t about policing private lives; it’s about whether taxpayers should be involuntary investors in expensive, experimental care.
Final Word: Accountability Matters
Anyone who cares about limited government, fiscal responsibility, and sensible medical policy should be alarmed by these trends. The debate over gender transition services is rightly complex and sensitive. But complexity is no excuse for handing public dollars to a growing industry without accountability. Lawmakers should act now to protect patients and taxpayers alike. If the “gender industrial complex” wants to prove it serves the public good, it should start by doing so without demanding the American people foot the bill by default.
